Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Express Scripts
Baxter
Johnson and Johnson
Harvard Business School

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Patent: 6,579,681

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 6,579,681
Title: Test system for detecting a splicing reaction and use thereof
Abstract:The present invention relates to a test system comprising (a) one or more identical or different immobilized nucleic acid(s) having at least one spliceable nucleic acid, (b) at least one gel-free detection system for detecting a splicing reaction, where appropriate (c) at least one composition comprising splicing components, and preferably (d) suitable detection probes, and, where appropriate, (e) further aids.
Inventor(s): Huls; Christoph (Herne, DE), Bauer; Bettina (Frankfurt, DE), Simandi; Claus (Frankfurt, DE), Luhrmann; Reinhard (Marburg, DE), Achsel; Tilmann (Gottingen, DE), Vornlocher; Hans-Peter (Bayreuth, DE)
Assignee: Aventis Research and Technologies GmbH & Co. KG (Frankfurt, DE)
Application Number:09/857,063
Patent Claims:see list of patent claims

Details for Patent 6,579,681

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Aventis Research and Technologies GmbH & Co. KG (Frankfurt, DE) 2019-03-02 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Aventis Research and Technologies GmbH & Co. KG (Frankfurt, DE) 2019-03-02 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Aventis Research and Technologies GmbH & Co. KG (Frankfurt, DE) 2019-03-02 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Harvard Business School
Merck
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.